Skip to main content
. 2013 Oct 17;109(11):2941–2950. doi: 10.1038/bjc.2013.647

Table 4. Type-specific HPV prevalences with exact binomial 95% confidence intervals (CI) by histologically confirmed cervical lesion.

  Histological diagnosis
 
No lesion (n=181)
CIN 1 (n=71)
CIN 2 (n=104)
CIN 3+ (n=63)
Type(s) n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI)
HPV 16
28
15.5 (10.5–21.6)
11
15.5 (8.0–26.0)
40
38.5 (29.1–48.5)
38
60.3 (47.2–72.4)
HPV 18
12
6.6 (3.5–11.3)
4
5.6 (1.6–13.8)
6
5.8 (2.1–12.1)
2
3.2 (0.4–11.0)
HPV 31
20
11.0 (6.9–16.5)
4
5.6 (1.6–13.8)
24
23.1 (15.4–32.4)
8
12.7 (5.6–23.5)
HPV 33
13
7.2 (3.9–12.0)
5
7.0 (2.3–15.7)
6
5.8 (2.1–12.1)
5
7.9 (2.6–17.6)
HPV 35
4
2.2 (0.6–5.6)
2
2.8 (0.3–9.8)
4
3.8 (1.1–9.6)
1
1.6 (0.04–8.5)
HPV 39
11
6.1 (3.1–10.6)
3
4.2 (0.9–11.9)
4
3.8 (1.1–9.6)
1
1.6 (0.04–8.5)
HPV 45
8
4.4 (1.9–8.5)
3
4.2 (0.9–11.9)
3
2.9 (0.6–8.2)
1
1.6 (0.04–8.5)
HPV 51
19
10.5 (6.4–15.9)
13
18.3 (10.1–29.3)
4
3.8 (1.1–9.6)
1
1.6 (0.04–8.5)
HPV 52
10
5.5 (2.7–9.9)
1
1.4 (0.04–7.6)
7
6.7 (2.7–13.4)
5
7.9 (2.6–17.6)
HPV 56
18
9.9 (6.0–15.3)
5
7.0 (2.3–15.7)
2
1.9 (0.2–6.8)
2
3.2 (0.4–11.0)
HPV 58
11
6.1 (3.1–10.6)
4
5.6 (1.6–13.8)
7
6.7 (2.7–13.4)
3
4.8 (1.0–13.3)
Group 1/2 Aa
136
75.1 (68.2–81.3)
51
71.8 (59.9–81.9)
88
84.6 (76.2–90.9)
57
90.5 (80.4–96.4)
Group 2Bb
23
12.7 (8.2–18.5)
13
18.3 (10.1–29.3)
4
3.8 (1.1–9.6)
1
1.6 (0.04–8.5)
Any HPV 163 90.1 (84.7–94.0) 65 91.5 (82.5–96.8) 92 88.5 (80.7–93.9) 58 92.1 (82.4–97.4)
a

Infection with one or more Group 1/2A HPV type (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68), coinfection with HPV types of Group 2B and/or Group 3 allowed.

b

Infection with one or more Group 2B HPV type (26, 30, 53, 66, 67, 69, 70, 73 and 82), coinfection with HPV types of Group 3 allowed.